Fundraising Fox

Cancer Prevention Pharmaceuticals

Tucson, US · Delaware corporation

Biotech

Founders & leadership

CR
Christopher RichiedExecutive
JJ
Jeffrey JacobNamed on SEC filing
EG
Eugene Gerner, Ph.D.Named on SEC filing

Board

JS
Jon SaxeBoard director
DD
Daniel DonovanBoard director
RL
Richard LoveBoard director

Reported raises · per SEC filings

Form D private placements

$11.9M disclosed across 5 rounds · 2015–2021

▶$400KraisedJan 2021 · 6 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard LoveDirector
  • John SaxeDirector
  • Eugene Gerner, Ph.D.Director
  • Jeffrey JacobExecutive Officer, Director
  • Daniel DonovanDirector
  • Andrew LevitchExecutive Officer
Offering amount
$3M
Amount sold
$400K
First sale
Jan 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedSep 2017 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Richard LoveDirector
  • Jeffrey JacobExecutive Officer, Director
  • Jon SaxeDirector
  • Christopher RichiedExecutive Officer
  • Eugene Gerner, Ph.D.Director
  • Daniel DonovanDirector
Offering amount
$5M
Amount sold
$5M
Minimum investment
$5M
First sale
Sep 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$700KraisedApr 2017 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Daniel DonovanDirector
  • Jon SaxeDirector
  • Jeffrey JacobExecutive Officer, Director
  • Christopher RichiedExecutive Officer
  • Eugene Gerner, Ph.D.Director
  • Richard LoveDirector
Offering amount
$3M
Amount sold
$700K
Minimum investment
$10K
First sale
Apr 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5MraisedJan 2016 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jon SaxeDirector
  • Eugene Gerner, Ph.D.Director
  • Jeffrey JacobExecutive Officer, Director
  • Richard LoveDirector
  • Daniel DonovanDirector
  • Christopher RichiedExecutive Officer
Offering amount
$5M
Amount sold
$5M
Minimum investment
$5M
Sales commissions
$250K
Placement agents
Financial West Group
First sale
Jan 2016
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$835KraisedJan 2016 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Jon SaxeDirector
  • Christopher RichiedExecutive Officer
  • Jeffrey JacobExecutive Officer, Director
  • Eugene Gerner, Ph.D.Director
  • Daniel DonovanDirector
  • Richard LoveDirector
Offering amount
$3M
Amount sold
$835K
Minimum investment
$25K
First sale
Dec 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Cancer Prevention Pharmaceuticals raised?
Cancer Prevention Pharmaceuticals has disclosed $11.9M raised across 5 rounds.
Where is Cancer Prevention Pharmaceuticals headquartered?
Cancer Prevention Pharmaceuticals is headquartered in Tucson, US.